The ticking clock of atrial fibrillation (AF) and stroke prevention in Indigenous Australians demands an urgent reevaluation of screening practices. The current recommendation to screen for AF at age 65 is a missed opportunity, as it fails to address the unique and alarming pattern of risk among Indigenous Australians. Our recent systematic review, published in the Medical Journal of Australia, reveals a startling truth: Indigenous Australians develop AF nearly 16 years earlier than their non-Indigenous counterparts, with almost half of AF cases occurring before age 55. This early onset of AF translates to a higher risk of stroke at younger ages, often with more severe outcomes, and a concerning lack of guideline-recommended therapies for Indigenous Australians with AF. The evidence is clear: AF screening must start earlier, and the recommended age of 55 is not arbitrary but a strategic response to the unique risk profile of Indigenous Australians. This is not merely a matter of technology; it's about systems of care that are responsive to the needs of Indigenous communities. Portable single-lead ECG devices have proven feasible and acceptable in Aboriginal Community Controlled Health Services, enabling opportunistic screening and early detection of AF. However, the journey doesn't end with detection. A structured clinical review is essential, encompassing diagnosis confirmation, stroke risk assessment, anticoagulation management, symptom control, and addressing co-existing cardiovascular risks. This requires clear referral routes, timely reviews, culturally safe communication, shared decision-making support, and adequate resourcing for Aboriginal Community Controlled Health Organisations and primary care teams. The call to action is clear: national leadership is needed to update AF screening recommendations, reflecting the evidence and the unique challenges faced by Indigenous Australians. The benefits of earlier screening are profound: preventing disability, preserving independence, and saving lives. It's a practical, evidence-based approach that can close the cardiovascular gap and ensure that Indigenous Australians receive the care they deserve. As we advocate for earlier AF screening, we must also acknowledge the role of community-led initiatives. Our earlier work, involving local co-design with Aboriginal communities and primary care services, has demonstrated the feasibility and acceptability of AF screening using portable devices. This collaborative approach, led by Indigenous health leaders like Katrina Ward, CEO of Brewarrina Aboriginal Medical Service, highlights the power of community-controlled care in addressing health disparities. In conclusion, the evidence is undeniable: earlier AF screening is a vital step towards stroke prevention in Indigenous Australians. By aligning screening with the realities of risk, we can make a tangible difference in the lives of Indigenous Australians, closing the cardiovascular gap and ensuring a healthier future for all.
